Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes

Table 2 Hepatitis C virus infection prevalence in the general population and in people who inject drugs in the most populated European countries

Country	Population (millions)1	Injecting drug use (rate/1000 inhabitants)2	HCV prevalence in the general population3	HCV prevalence in PWID4
Germany	80.4	4.25-5.04	0.7	51
France	65.6	6.7-8.8	0.85	73
United Kingdom	63.7	3.3	0.6	47.9
Italy	59.5	10	3.0	61.0-64.8
Spain	41.0	0.2	1.5	73.3-85.9
Poland	38.5	2.9	1.5	44.3 72.4
Romania	20.0	NA	2.1-2.4	82.4
Netherlands	16.7	0.2	0.2	50-86
Greece	10.9	1.1	> 1.5	60-73
Sweden	9.5	4.9	0.5	83

Data sources:

¹World health statistics 2014 (available from: http://www.who.int/world_health_statistics; ^2,4ECMDDA, 2013[33];

³Mühlberger N, 2009[30] and Cornberg M, 2011[16]. NA: Not available. PWID: People who inject drugs; HCV: Hepatitis C virus.